Privia Health Group, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Privia Health Group, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 258.69K shares, a 15.67% increase year-over-year.
- Privia Health Group, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 128.22K shares, a 60.74% decline year-over-year.
- Privia Health Group, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 243.45K shares, a 12.24% decline year-over-year.
- Privia Health Group, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 179.86K shares, a 57.09% decline year-over-year.
- Privia Health Group, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 973.51K shares, a 22.71% decline from fiscal 2024.
- Privia Health Group, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 1.26M shares, a 59.43% decline from fiscal 2023.
- Privia Health Group, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 3.10M shares, a 53.50% decline from fiscal 2022.
- Privia Health Group, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 6.68M shares, a 244.95% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 258.69K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 810.21K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 128.22K shares 10-Q · filed 2026-05-07 | 775.17K shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 243.45K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 973.51K shares 10-K · filed 2026-02-27 |
| 2025-09-30 | 179.86K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 1.01M shares derived: sum of 4 quarters · filed 2026-02-27 |
| 2025-06-30 | 223.64K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 1.25M shares derived: sum of 4 quarters · filed 2026-02-27 |
| 2025-03-31 | 326.56K shares 10-Q · filed 2025-05-08 | 1.13M shares derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-12-31 | 277.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 1.26M shares 10-K · filed 2026-02-27 |
| 2024-09-30 | 419.18K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 1.24M shares derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | 106.04K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 1.70M shares derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | 456.89K shares 10-Q · filed 2024-05-09 | 2.92M shares derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | 259.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 3.10M shares 10-K · filed 2026-02-27 |
| 2023-09-30 | 874.83K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | 3.67M shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | 1.33M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | 7.00M shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | 639.71K shares 10-Q · filed 2023-05-04 | 6.88M shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | 820.57K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 6.68M shares 10-K · filed 2025-02-27 |
| 2022-09-30 | 4.21M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 7.46M shares derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | 1.22M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 3.57M shares derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | 431.80K shares 10-Q · filed 2022-05-12 | 2.37M shares derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | 1.61M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | 1.94M shares 10-K · filed 2024-02-27 |
| 2021-09-30 | 311.72K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | |
| 2021-06-30 | 16.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | |
| 2021-03-31 | 0.00 shares 10-Q · filed 2021-05-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |